Homepage
FRESH Analysis Report
Jun 10, 2026
2 days ago · 100% complete · +6 refreshed

Embraer S.A.

EMBJ NYSE Categories PDF
Industrials · Aerospace & Defense
São Paulo, SP 05425-070, Brazil IPO 2025 embraer.com Updated Jun 10, 3:00am
Price
$56.30
Market Cap
$10.3B
Employees
20,923
Beta
0.73
Avg Volume
1,801,914
CEO
Francisco Gomes Neto
Business Description

Embraer S.A. is a leading Brazilian firm operating within the aerospace and defense sectors. Its extensive activities encompass the full lifecycle of various aircraft, from their initial design and development through manufacturing and ongoing servicing. This includes a diverse fleet of commercial airliners, executive private jets, and specialized agricultural planes. Beyond its aviation portfolio, the company also delivers advanced defense and security solutions and is a key player in the emerging field of eVTOL (electric Vertical Takeoff and Landing) technologies.

Business History
Generated: Jun 10, 2026 3:03am
Price Overview
Last updated: Jun 10, 2026 3:00am (2d ago)
$56.30
-0.24 (-0.42%)
Day Range
$54.93 – $57.84
52-Week Range
$46.54 – $80.75
50-Day MA
$61.46
200-Day MA
$63.62
Volume
1,145,891.00
Analyst Price Targets
Low $65.00
Consensus $73.00
High $81.00
(14 analysts)
Share Structure
Outstanding 45,878,793.00
Float 42,878,779.00
Free Float 93.5%
High free float — 93.5% of shares trade freely, ~6.5% held by insiders/institutions
Very liquid — most shares trade freely. Low insider ownership can mean less management alignment, but makes large position sizing straightforward.
Price History (1 Year)
Last updated: Jun 10, 2026 3:07am (2d ago)
Revenue & Net Income Trend
The directional story — useful even when net income is negative.
Last updated: Jun 10, 2026 3:07am (2d ago)
Revenue
The top line — total sales before any costs or taxes are subtracted. A measure of how much business the company is doing.
Net Income
The bottom line — profit left after subtracting all expenses, interest, and taxes from revenue. Reflects accounting profitability, but includes non-cash items like depreciation, so it isn't the same as cash earned.
Operating Cash Flow
The real cash generated by the day-to-day business — selling products, paying suppliers, collecting from customers. Calculated from net income by adding back non-cash items and adjusting for timing (unpaid bills, unsold inventory). When OCF consistently lags net income, the reported profit may not be converting to real money.
Period Revenue Net Income Net Margin YoY/QoQ
Key Metrics
API Direct from provider CALC Derived from statements
Industry comparison last run: Jun 10, 2026 3:02am
P/E Ratio (Price per dollar of earnings)
API
Stock Price / EPS (Diluted)
32.37
Stock Price: $56.30
EPS (Diluted): 10.52
P/B Ratio (Price vs net asset value)
API
Stock Price / Book Value Per Share
3.42
Stock Price: $56.30
Total Equity: $18.87B
Shares: 183,284,992
EV/EBITDA (Total value vs operating profit)
API
Enterprise Value / EBITDA
13.78
Market Cap: $10.33B
Total Debt: $14.21B
Cash: $10.68B
EBITDA: $3.97B
Enterprise Value (Takeover price (cap + debt - cash))
API
Market Cap + Total Debt - Cash
$68.8B
Market Cap: $10.33B
Total Debt: $14.21B
Cash: $10.68B
Gross Margin (Revenue left after direct costs)
API
Gross Profit / Revenue
17.5%
Gross Profit: $7.28B
Revenue: $41.50B
Operating Margin (Revenue left after all operations)
API
Operating Income / Revenue
8.0%
Operating Income: $3.33B
Revenue: $41.50B
Net Margin (Revenue left as actual profit)
API
Net Income / Revenue
4.6%
Net Income: $1.93B
Revenue: $41.50B
ROE (Profit from shareholder equity)
API
Net Income / Total Equity
9.1%
Net Income: $1.93B
Total Equity: $18.87B
ROIC (Profit from all invested capital)
API
NOPAT / Invested Capital
7.3%
Operating Income: $3.33B
Tax Rate: -34.2%
Equity: $18.87B
Total Debt: $14.21B
Cash: $10.68B
Current Ratio (Can it pay short-term bills)
API
Current Assets / Current Liabilities
1.50
Current Assets: $39.16B
Current Liabilities: $26.08B
Debt/Equity (Leverage — debt vs equity)
CALC
Total Debt / Total Equity
0.75
Short-Term Debt: $576.73M
Long-Term Debt: $13.63B
Total Debt: $14.21B
Total Equity: $18.87B
Rev/Share (Top-line per share)
CALC
Revenue / Shares Outstanding
$226.43
Revenue: $41.50B
Shares: 183,284,992
Book Value/Share (Net assets per share)
CALC
(Total Assets - Total Liabilities) / Shares
$102.94
Total Equity: $18.87B
Shares: 183,284,992
FCF/Share (Real cash generated per share)
CALC
(Operating Cash Flow + CapEx) / Shares
$11.54
Operating CF: $4.76B
CapEx: -$2.65B
Shares: 183,284,992
CapEx is negative (outflow) — added to OCF to get FCF
Div Yield (Annual income from holding)
API
Last Annual Dividend / Stock Price
0.2%
Last Dividend: N/A
Stock Price: $56.30
Payout Ratio (Earnings paid out as dividends)
Dividends Paid / Net Income
Dividends Paid: N/A
Net Income: $1.93B
Dividends paid not available in cash flow statement
Industry Benchmarks
Last run: Jun 10, 2026 3:02am
Compares EMBJ against LLM-researched typical ranges for its industry. One research call per industry, cached indefinitely — every stock in the same industry reuses the same baseline.
Deep Analysis
Last run: Jun 10, 2026 3:06:33 am

Pre-flight intelligence scans the company first, then routes to the right analytical methods.

0 Company Classification — What type of company is this?
1 Industry Landscape — Where is the industry headed?
2 Company Momentum — Where is this company trending?
3 Forward Projection — 1Y & 2Y projected metrics (requires Layer 1 + 2)
4a DCF Valuation — Present value of future cash flows
4b Earnings Power Value — Floor value — worth with zero growth
4c Anchored PE — Industry PE adjusted for growth differential
4d Reverse DCF — What growth is the market pricing in?
4e Revenue-Based DCF — For growth/narrative companies (skip if mature earner)
Not applicable for High Growth Profitable companies
4f Anchored P/S — Price-to-Sales peer comparison (skip if mature earner)
Not applicable for High Growth Profitable companies
4g Scenario Analysis — Bull / Base / Bear (skip if mature earner)
Not applicable for High Growth Profitable companies
4h Dividend Discount Model — For dividend/income stocks only
Not applicable for High Growth Profitable companies
4i Book Value Analysis — For deep value / turnaround stocks only
Not applicable for High Growth Profitable companies
4j Insider Activity — Are insiders buying or selling?
4f Cash Flow Quality — How trustworthy is the FCF?
4g Debt Maturity Risk — Can it handle its debt?
4h Macro Environment — Rates, market valuation, volatility
4i Sector Intelligence — How does this company compare within its sector?
4j Revenue Confidence — How reliable is the growth projection?
4k Sensitivity Analysis — How fragile is the fair value estimate?
4l Sector Demand Cycle — Is the sector in a boom, steady state, or contraction?
5 AI Investigation — Adaptive research engine (Claude)
5b Thesis Evaluation — What does the market believe? (narrative/platform stocks only)
Not applicable for High Growth Profitable companies
6 Valuation Synthesis — Weighted verdict from all methods (requires Layer 4)
Income Statement (Annual)
Last updated: Jun 10, 2026 3:07am (2d ago)
Metric 2021 2022 2023 2024 2025
Revenue $4.2B $4.5B $5.3B $6.4B $41.5B
Cost of Revenue $3.5B $3.6B $4.4B $5.2B $34.2B
Gross Profit $655.9M $912.2M $909.6M $1.2B $7.3B
Operating Expenses $458.3M $1.0B $595.1M $485.6M $3.9B
Operating Income $201.3M -$110.5M $314.5M $667.5M $3.3B
Net Income -$44.7M -$185.4M $164.0M $352.5M $1.9B
EBITDA $479.9M $228.4M $598.2M $1.0B $4.0B
EPS $-0.24 $-1.00 $0.88 $1.92 $10.52
EPS (Diluted)
Balance Sheet (Annual)
Last updated: Jun 10, 2026 3:03am (2d ago)
Metric 2021 2022 2023 2024 2025
Cash & Equivalents $1.8B $1.8B $1.6B $1.6B $10.7B
Total Current Assets $5.9B $5.8B $6.1B $6.5B $39.2B
Total Assets $10.2B $10.1B $10.8B $11.8B $70.8B
Current Liabilities $2.8B $3.2B $3.7B $4.4B $26.1B
Long-Term Debt $3.5B $2.9B $2.8B $2.4B $13.6B
Total Liabilities $7.4B $7.3B $7.7B $8.5B $49.9B
Total Equity $2.7B $2.6B $2.8B $3.1B $18.9B
Retained Earnings $0 $0 $0 $0 $0
Cash Flow (Annual)
Last updated: Jun 10, 2026 3:07am (2d ago)
Metric 2021 2022 2023 2024 2025
Operating Cash Flow $515.3M $751.3M $617.0M $871.2M $4.8B
Capital Expenditure -$268.2M -$256.0M -$430.8M -$466.2M -$2.7B
Free Cash Flow $247.1M $495.3M $186.2M $405.0M $2.1B
Acquisitions (net) -$1.1M $-400,000 -$24.0M -$18.3M -$67.4M
Debt Repayment
Dividends Paid
Stock Buybacks -$2.5M $0 $0 $0 -$1.0B
Net Change in Cash -$44.5M -$23.0M -$189.3M -$63.3M $2.1B
Analyst Estimates (Annual)
Last updated: Jun 10, 2026 3:00am (2d ago)
Metric 2027 2028 2029 2030
Revenue $9.6B
$9.4B – $9.7B
$10.4B
$10.1B – $11.1B
$10.1B
$9.8B – $10.8B
$10.8B
$10.4B – $11.5B
EBITDA $1.0B
$998.2M – $1.0B
$1.1B
$1.1B – $1.2B
$1.1B
$1.0B – $1.1B
$1.1B
$1.1B – $1.2B
Net Income $665.8M
$596.9M – $758.3M
$786.4M
$756.2M – $852.2M
$753.3M
$724.4M – $816.3M
$844.9M
$812.5M – $915.6M
EPS
Growth Trends (YoY %)
Last updated: Jun 10, 2026 3:07am (2d ago)
Metric 2022 2023 2024 2025
Revenue Growth +8.1% +16.0% +21.4% +549.0%
Gross Profit Growth +39.1% -0.3% +26.8% +531.1%
Operating Income Growth -154.9% +384.6% +112.2% +399.3%
Net Income Growth -314.8% +188.5% +114.9% +446.8%
EBITDA Growth -52.4% +161.9% +69.4% +291.5%
Insider Trading (Recent)
Last updated: Jun 10, 2026 3:06am (2d ago)
Type codes PPurchase SSale AAward / grant MOption exercise FIn-kind (tax) CConversion GGift DReturn to issuer
All SEC Form 4 codes
Open market
P Purchase
Open-market or private purchase of shares.
S Sale
Open-market or private sale of shares.
Compensation (Rule 16b-3)
A Award / grant
Grant or award of securities (RSUs, options, etc.) under Rule 16b-3.
D Return to issuer
Securities disposed back to the company under Rule 16b-3.
F In-kind (tax)
Shares withheld or delivered to pay the option-exercise price or tax — not an open-market sale.
I Discretionary
Discretionary transaction under an employee plan — Rule 16b-3(f).
M Option exercise
Exercise or conversion of a derivative (option/RSU) into shares — exempt.
Derivatives
C Conversion
Conversion of a derivative security into the underlying shares.
E Short expiration
Expiration of a short derivative position.
H Long expiration
Expiration or cancellation of a long derivative position with value received.
O OTM exercise
Exercise of an out-of-the-money derivative.
X ITM exercise
Exercise of an in-the-money or at-the-money derivative.
Other exempt
G Gift
Bona fide gift of securities.
L Small acquisition
Small acquisition under Rule 16a-6.
W Inheritance
Acquisition or disposition by will or the laws of descent.
Z Voting trust
Deposit into or withdrawal from a voting trust.
Other
J Other
Other acquisition or disposition (explained in a Form 4 footnote).
K Equity swap
Transaction in an equity swap or similar instrument.
U Tender / buyout
Disposition via tender of shares in a change-of-control transaction.

Compensation-plan codes (A, D, F, M) are routine and rarely directional. Open-market P (buy) and S (sale) carry the most signal.

Date Insider Type Shares Price Value
2026-04-23 Chaves Roberto de Deus A-Award 6,222.00 $0.00 $0
2026-04-23 Silva Luis Carlos Marinho da A-Award 9,540.00 $0.00 $0
2026-04-23 Neto Francisco Gomes A-Award 41,279.00 $0.00 $0
2029-04-23 de Lima Felipe Santana Santiago 5,600.00 $0.00 $0
2026-03-18 McAllister Kevin Gregory 0.00 $0.00 $0
2026-03-18 Pedreiro Nelson 0.00 $0.00 $0
2026-03-18 Calfat Raul 0.00 $0.00 $0
2026-03-18 Pego Maria A. Rosina Tedesco de Oliveira 0.00 $0.00 $0
2026-03-18 Freeman Todd Messer 0.00 $0.00 $0
2028-03-13 Neto Francisco Gomes 48,769.00 $0.00 $0
2026-03-18 Medeiros Mauricio Augusto Silveira de 0.00 $0.00 $0
2026-03-18 Silva Luis Carlos Marinho da 0.00 $0.00 $0
2028-03-13 Silva Luis Carlos Marinho da 10,889.00 $0.00 $0
2028-03-13 Chaves Roberto de Deus 6,351.00 $0.00 $0
2026-03-18 Rosa Marcio Fernando Elias 0.00 $0.00 $0
2028-03-13 Garcia Antonio Carlos 13,931.00 $0.00 $0
2026-03-18 Kern Junior Mauro 0.00 $0.00 $0
2026-03-18 Ramirez Claudia Sender 0.00 $0.00 $0
2026-03-18 Saes Edmilson 0.00 $0.00 $0
2026-03-18 Ioschpe Dan 0.00 $0.00 $0
Dividend History (Last 20)
Last updated: Jun 10, 2026 3:00am (2d ago)
Date Dividend Declaration Record Payment
2026-05-15 $0.01 2026-05-05 2026-05-15 2026-05-28
2025-12-19 $0.55 2025-12-09 2025-12-19
2025-05-16 $0.05 2025-05-06 2025-05-16 2025-06-02
2018-12-28 $0.01 2018-12-17 2018-12-31 2019-01-18
2018-09-26 $0.01 2018-06-13 2018-09-27 2018-10-18
2018-06-27 $0.02 2018-06-18 2018-06-28 2018-07-20
2018-04-25 $0.08 2018-04-16 2018-04-26 2018-05-29
2018-03-19 $0.03 2018-03-07 2018-03-20 2018-04-18
2017-12-27 $0.11 2017-12-14 2017-12-28 2018-02-02
2017-09-19 $0.05 2017-09-07 2017-09-20 2017-10-16
2017-06-13 $0.05 2017-06-06 2017-06-15 2017-07-20
2017-04-25 $0.13 2017-04-17 2017-04-27 2017-05-17
2017-03-21 $0.05 2017-03-09 2017-03-23 2017-04-20
2016-09-27 $0.02 2016-09-16 2016-10-21
2016-06-21 $0.05 2016-06-10 2016-07-21
2016-03-22 $0.04 2016-03-11 2016-04-21
2015-12-22 $0.04 2015-12-11 2015-12-24 2016-01-21
2015-08-18 $0.05 2015-10-21
2015-06-23 $0.05 2015-06-12 2015-06-25 2015-07-20
2015-04-28 $0.03 2015-04-17 2015-04-30 2015-05-20
Narrative Economics
The story the market is telling about this stock — the intangible X-factor (founder mythology, cult dynamics, TAM-of-imagination) that moves price beyond what cash flows alone explain. After Shiller, Narrative Economics.
No narrative profile yet for EMBJ.
Delvantic AI Findings
Independent analyst synthesis · Delvantic - Cairn AI · generated 2026-06-10 03:07:10
Reviews the pipeline's own verdicts
Verdict Fairly valued around $56 on clean numbers (~23x TTM EPS, 1.3x sales) — prior models' "disconnected from fundamentals" call is a data-corruption artifact, not a mispricing; hold,

The data file is corrupted in ways that make every downstream model unreliable, and the synthesis layer's "priced for corporate death" verdict is essentially hallucinating off bad inputs. The 2025 annual revenue of $41.5B is nonsensical for a company whose quarterly prints sum to roughly $7.6B (Q1 $1.10B + Q2 $1.82B + Q3 $2.04B + Q4 $2.65B). The 2024 annual at $6.39B is the credible anchor. So actual 2025 revenue growth is roughly $7.6B vs $6.39B, or ~19% — solid for an aerospace OEM but nothing like the 549% YoY or 180% CAGR the momentum module spits out. Similarly, the Q1 2026 print of $7.44B is almost certainly a full-year figure or a cumulative line item misclassified as quarterly; Embraer doesn't do $7.4B in a quarter when it did $2.65B the prior one. Every model downstream of these numbers inherits the error. The "Disconnected from Fundamentals" thesis collapses once you realize the disconnect is in the data feed, not the tape.

Rebuilt from the clean quarterly trajectory: TTM revenue ~$7.6B, TTM net income ~$450M (Q2-25 through Q1-26: $78.5+$116.7+$83.3+$171.6 = $450M), implying a real P/E around 23x at $10.3B market cap — not the 5.4x the thesis evaluator cites, and not the 32x in the canonical metrics either (which is contaminated by the bogus annual). EV/sales of ~1.3x on clean revenue, with $10.7B cash on the balance sheet, is genuinely interesting if that cash figure is real — though I'd flag it as suspect too, since $10.7B cash against a $10.3B market cap would imply the operating business trades near zero, which is implausible for a profitable OEM with a real backlog. More likely the cash line includes customer deposits/advances tied to the order book, which is standard for aerospace and not freely distributable. Operating CF of $4.76B on the annual is also inflated by the same scaling error; real OCF is probably $700-900M and FCF closer to break-even or modestly positive after $400-600M of capex.

The narrative layer is the most useful artifact here because it doesn't depend on the broken numbers. The turnaround-bet framing is right: Embraer is a cyclical EM industrial with three real call options (E-Jet E2 backlog refresh, KC-390 defense traction, Eve eVTOL). The bear case — Brazilian domicile, cyclicality, eVTOL with no unit economics — is empirically grounded and the reason the stock should not trade at Boeing/Airbus multiples. A contrarian read: the 30% drawdown from 52-week highs likely reflects (a) tariff/trade noise on Brazilian exports into the US, (b) softening regional jet order momentum as US regional carriers face pilot/scope-clause issues again, and (c) Eve burn that is real cash out the door for revenue that is years away. None of the prior models engaged with the tariff risk, which for a Brazilian aerospace exporter to US customers is the single most underwritten near-term overhang.

I dissent from the synthesis verdict of "Disconnected from Fundamentals" — that conclusion is an artifact of corrupted inputs, not a real market mispricing. On clean numbers, EMBJ at $56 trades around 23x TTM earnings, ~1.3x sales, with mid-single-digit net margins expanding off a turnaround base, a real but cyclical backlog, and an eVTOL option that's a coin flip. That's a reasonable-to-slightly-full price for a cyclical EM aerospace name, not a screaming bargain and not a death-spiral mispricing. Fair value is probably $50-65 depending on how you handicap Eve and tariff risk; the stock is roughly where it should be. The "high_growth_profitable" archetype classification is wrong — this is cyclical-recovery, not secular growth — and the rule-based confidence of 0.68 should have been overridden once the momentum numbers blew past 180% CAGR (which should have triggered a data-integrity halt, not a verdict).

GPT Critique
Second-opinion review · gpt-4o · generated 2026-06-10 03:07:19
Reviews the Opus findings above
Verdict I agree with Opus — fairly valued at $56, with a range of $50-65; Opus correctly identifies data errors and realistic growth prospects, supporting a hold recommendation.

In my independent analysis of Embraer S.A., the key standout is the apparent misalignment between the raw data and typical market expectations. The reported 2025 revenue of $41.5 billion is clearly an anomaly, as it vastly exceeds the plausible quarterly figures that sum to approximately $7.6 billion. This suggests an input error rather than a genuine financial performance. The corrected growth trajectory, with 2025 revenue at ~$7.6 billion compared to $6.39 billion in 2024, places the real growth rate at around 19%. This is consistent with a solid, but not extraordinary, performance for an aerospace OEM. Furthermore, the Q1 2026 revenue figure of $7.44 billion seems misclassified, likely representing an annual or cumulative figure rather than a single quarter's earnings.

I agree with Claude Opus's assessment that the data corruption in the revenue figures significantly skews the analysis. The misreported annual revenue numbers drastically distort the calculated P/E and P/S ratios, leading the "Disconnected from Fundamentals" thesis to appear disconnected from reality. Opus's reconstruction of the corrected P/E at approximately 23x based on a $10.3 billion market cap and TTM net income of around $450 million aligns with a typical valuation for a company in Embraer's sector, given its cyclical nature and emerging market risks.

Opus's narrative on the turnaround-bet archetype is also persuasive. Embraer's positioning as a cyclical EM industrial with call options on regional jets, defense, and eVTOL is a credible strategic framing. The bear case, emphasizing Brazilian domicile risks, cyclicality, and speculative eVTOL economics, is well-argued and rightly tempers the bullish narrative. I agree that the market's current pricing likely reflects these risks, particularly given the recent 30% drawdown from its 52-week high, which could be attributed to geopolitical trade concerns and regional jet market dynamics.

Where I diverge slightly from Opus is on the interpretation of the cash figures. While he suggests the $10.7 billion cash position might be inflated by customer deposits, the relative pricing still indicates a significant cash buffer, albeit not freely distributable. This financial structure, typical for aerospace companies, aligns well with the operational cash flow figures he recalibrated to $700-900 million, supporting a more balanced view of Embraer's liquidity and investment capacity.

A careful skeptic might argue that both Opus's and my assessment underplay the potential upside of the eVTOL market. If Embraer can successfully capitalize on its first-mover advantage in this area, the speculative TAM could provide a significant long-term growth driver, challenging the current valuation. Conversely, the geopolitical and macroeconomic risks inherent in operating as a Brazilian aerospace company could be more severe than either assessment has accounted for, potentially justifying a more conservative valuation.

Advanced Analysis Forensic deep-dive · two lenses
Two separate reads — Company Quality (is it a great business?) and Valuation (is it mispriced?), kept deliberately apart · 2026-06-10 03:08:45
Delvantic - Cairn AI
Quality — wait for a dip 7/10
Real turnaround in a structurally advantaged franchise (+25 quality), but price has run ahead of the story (-86 value) — this is a wait, not a buy.
The cruxWhether you accept reported peak-recovery earnings at face value or haircut them for the data anomalies and cycle risk — that one call moves fair value from the mid-$40s to the mid-$50s.
Company Quality
+25
Solid
edge √Σ 127 · risk √Σ 102 · conf 6/10
Valuation / Mispricing
-86
Rich
edge √Σ 30 · risk √Σ 116 · conf 6/10
Liquidity & RunwaySelf-Funding
DilutionStable Share Count
Earnings QualityWeak — Some Red Flags
The Play — combined read across both lenses Delvantic - Cairn AI

The two lenses are telling a coherent story, not a contradictory one: Lens 1 at +25 says yes, Embraer is genuinely a better business than it was — margins inflected, FCF positive, zero dilution, $14B liquid cash, #3 global commercial OEM with defense and Eve optionality. Lens 2 at -86 says the market already knows all of that and then some, having tripled the stock and capitalized the eVTOL dream on top of peak-recovery A&D earnings whose quality is flagged (Beneish 1.96, an implausible 2025 revenue print, distorted OCF/NI). When a Solid-not-Elite business trades at a Rich multiple with no insider buying to validate it, I don't chase. I sit.

My play: zero position today at $56.30. I set an alert at $46 and a real buy zone $40-44 — that's where the value lens says margin of safety appears and where I'd treat any commercial aviation wobble, defense budget scare, or Eve disappointment as a gift rather than a thesis break. Entry style is scale-in thirds: starter at $44, add at $40, full weight only below $38 or on a clean quarter that resolves the earnings-quality flags. Target full position ~2-3% of book given it's a cyclical OEM with speculative optionality, not a compounder I'd anchor a portfolio on. What flips me aggressive earlier: an open-market insider P-buy of size, or a clean reconciled 10-F that kills the 2025 revenue anomaly and confirms normalized ~$6-7B revenue with sustained 8-10% op margins. What keeps me on the sidelines indefinitely: price drifting higher on Eve hype without the underlying numbers cleaning up. Right now the trade is patience.

The evidence behind each score — switch lenses
+25 Solid edge √Σ 127 · risk √Σ 102 · conf 6/10

Embraer's operating trajectory has clearly inflected: gross margin sits at 17-18%, operating margin climbed from -2.4% in 2022 to 8-10% in 2024-2025, and net income swung from -$185M to positive $352M (2024) on a normalized revenue base around $6.4B. Free cash flow has been positive every year shown ($186M-$495M in the normal years), and the diluted share count is essentially flat at ~183.7M — no dilution drag, which is rare for an aerospace OEM coming out of a downcycle. Liquid cash of $14.4B against a modest net cash position of $176M indicates the company runs with massive gross cash but also substantial gross debt — typical for aerospace working capital (customer advances, program financing).

The 2025 revenue line of $41.5B is almost certainly a data artifact (BRL vs USD mixing, or a reporting unit error) — a 6.5x YoY jump with margins unchanged is not operationally credible for an aerospace OEM. I'm treating the underlying business as the ~$6-7B revenue franchise with ~8-10% operating margins and ~$400M-$2B FCF range. Earnings quality flags (Beneish 1.96, accruals -5.5%, OCF/NI -1.37x) and Altman Z of 1.09 deserve weight, though Altman is notoriously unreliable for aerospace given the working-capital structure (customer deposits inflate liabilities). The Beneish flag combined with the suspicious 2025 revenue line is what keeps me from a 'Strong' grade.

Insider tape shows only equity awards (A-codes) and zero open-market buys or sells — neutral signal. The duopoly+1 position in regional jets (E-Jets E2), growing defense (KC-390) and Eve eVTOL optionality give the business real durability, but the quality verdict hinges on cleaning up the financial-data integrity issues.

Strengths 4
m75
Genuine margin and profit inflection
Operating margin moved from -2.4% (2022) to 10.4% (2024); net income from -$185M to +$352M; FCF positive every year ($186M-$495M in normal years). This is a real operational turnaround, not accounting.
m70
Zero dilution discipline
Diluted shares flat at ~183.7M across five years (-0.1% CAGR), SBC effectively 0% of revenue, buyback/SBC ratio massive. Per-share value is being protected — uncommon for a recovering aerospace OEM.
m60
Massive liquid cash buffer
$14.4B liquid cash provides enormous program-funding runway; even after gross debt, net cash is +$176M. Survives any aerospace downcycle.
m45
Durable franchise position
#3 global commercial aircraft OEM with the dominant regional jet platform (E2), growing defense (KC-390), and Eve eVTOL optionality — structural duopoly-adjacent moat.
Concerns 4
m70
2025 revenue figure is not credible
$41.5B revenue vs $6.39B in 2024 with unchanged ~17.5% gross margin and similar margin structure is operationally impossible for an aerospace OEM. Almost certainly a currency unit (BRL) or data-feed error — undermines confidence in the derived dataset.
m55
Beneish M-score flag at 1.96
Above the -1.78 threshold indicates statistically elevated earnings-manipulation indicators. Combined with accruals -5.5% of assets and OCF/NI of -1.37x (distorted by the 2025 data issue), warrants forensic checking of revenue recognition on long-cycle aircraft contracts.
m40
Altman Z in distress zone at 1.09
Z<1.81 is classic distress territory. However, this model is unreliable for aerospace OEMs where customer pre-delivery payments inflate current liabilities. Worth noting but not dispositive given the $14.4B cash position.
m30
No insider conviction signal
Insider tape shows only A-code equity awards; zero open-market P-buys. No reinforcing 'skin in the game' signal from management to validate the turnaround narrative.
This looks like a real turnaround in a structurally advantaged franchise — margins are up, FCF is positive, share count is flat, cash is enormous. But I can't grade it higher than Solid because the dataset itself is compromised: the 2025 revenue print is not believable, and the Beneish flag plus distorted OCF/NI ratio means I'm partly looking at noise rather than fundamentals. The underlying business — #3 in commercial aircraft, growing defense, Eve optionality, no dilution, big cash — has the bones of a Strong-quality industrial. I'd want clean financials and management commentary before upgrading. The forensic flags I'd interpret as data-integrity issues more than fraud risk, but a forensic analyst doesn't get to assume that — verify first.
Verify before trusting this (7)
  • Reconcile 2025 revenue figure — verify whether $41.5B is a BRL-denominated figure mistakenly tagged USD; true 2025 USD revenue likely $7-8B
  • Customer concentration in commercial backlog (American, Porter, SkyWest exposure) and KC-390 export contracts
  • Working capital mechanics — split of customer advances vs trade payables to properly interpret Altman Z and accruals
  • Revenue recognition policy on long-cycle aircraft contracts to address Beneish flag
  • Gross debt vs cash composition — duration and currency mix of the $14B+ liquid cash and offsetting debt
  • Eve Air Mobility cash burn and dilution exposure to parent
  • FX hedging policy given BRL cost base vs USD revenue base
-86 Rich edge √Σ 30 · risk √Σ 116 · conf 6/10
Price $56.30 vs deserved ~$45-50 after earnings-quality haircut — roughly 10-20% above fair, no margin of safety. attractive below $44.00

EMBJ has roughly tripled from its multi-year base on a genuine operational turnaround, and the e2e synthesis itself flags the stock as 'Disconnected from Fundamentals.' At $56.30 (≈$10.3B market cap), the shares are capitalizing not just the recovered commercial/exec aviation franchise but also a meaningful slug of Eve eVTOL optionality whose unit economics are unproven. The bull case requires all three legs — regional jet revival, defense expansion, and eVTOL — to land; the bear case (cyclical A&D manufacturer, shrinking regional jet TAM, speculative eVTOL TAM) is at least as plausible.

Deserved value is hard to pin precisely because the Company-Quality lens explicitly flags the 2025 revenue print as not believable, a Beneish red flag, and an OCF/NI distortion — earnings quality is weak, which argues for a HAIRCUT to any DCF/multiple-based fair value, not a premium. On a cleaner mid-cycle A&D multiple (~12-14x EV/EBIT) applied to normalized — not peak — earnings, deserved value sits closer to the mid-$40s, with the eVTOL call option worth a few dollars on top. That puts price modestly above deserved, not screamingly expensive but with no margin of safety for a cyclical, capital-intensive turnaround.

Cheap signals 1
m30
Fortress liquidity and clean turnaround support a higher floor
Large cash position and flat share count mean the business deserves a higher multiple than its distressed-era levels — this limits downside but does not by itself make $56 cheap.
Rich / priced-in 4
m70
E2E synthesis flags 'Disconnected from Fundamentals'
The composite valuation lens itself concludes price has run ahead of fundamentals — a direct mispricing-to-the-upside signal that I should not ignore.
m60
Earnings-quality haircut required
Beneish red flag, distorted OCF/NI ratio, and a 'not believable' 2025 revenue print mean fair-value inputs are likely overstated. Any DCF or multiple anchored on reported numbers needs to be marked down, lowering deserved value.
m55
Heroic triple-engine story embedded in price
To justify $56 you need regional jet demand to keep recovering, defense backlog to scale at margin, AND Eve eVTOL to become a real business. eVTOL has zero proven unit economics — paying for it today is paying for a call option at intrinsic-plus.
m45
Cyclical A&D at/above cycle multiples
Embraer is a capital-intensive cyclical OEM. Paying a full-cycle multiple on what may be peak-recovery earnings leaves little room if commercial aviation cycles or defense budgets normalize.
I'm not paying $56 for this. The business is genuinely better than it was, but the e2e lens already tells me price has separated from fundamentals, and the earnings-quality flags mean the numbers I'd use to defend a higher fair value are themselves suspect. I'd want this in the mid-$40s before the risk/reward on a cyclical OEM with a speculative eVTOL kicker starts to look interesting. Calling it Rich, not Overvalued — the turnaround is real, but the margin of safety isn't there.
Verify before trusting this (5)
  • Reconciliation of the questionable 2025 revenue print — is it a reporting/segment-restatement artifact or real growth?
  • Eve eVTOL: latest order book, certification timeline, and any capital commitments from Embraer parent
  • Commercial backlog composition and pricing — how much is firm vs options, and book-to-bill trajectory
  • Defense segment margins and contract mix to test whether the recent margin step-up is structural
  • Any one-time items (FX gains, tax benefits, deferred revenue) inflating recent EBIT/FCF
Two lenses kept deliberately separate — Company Quality is price-agnostic; Valuation is price-conditional. The scores are not blended (yet). Filing-level items (convertibles, lock-ups, customer concentration) are v2 — see each lens's "verify."
Community AI Feedback
No community reviews yet for EMBJ. Be the first — hit How to Contribute, have any AI review this page, and paste its take back here.
My Notes personal — only you see this
Data via Financial Modeling Prep · Cached for performance · fmp
v1.1.330 · 344c2a54 · 2026-06-09 20:20:16